| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 09/18/1997 | WO1997033531A1 Oral peptide pharmaceutical products |
| 09/18/1997 | WO1997007815A3 Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis |
| 09/18/1997 | CA2249733A1 Spirocycle integrin inhibitors |
| 09/18/1997 | CA2248549A1 Extracellular matrix signalling molecules |
| 09/18/1997 | CA2247804A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 09/17/1997 | EP0794771A1 Method of using triaryl-ethylene derivatives in the treatment and prevention of osteoporosis |
| 09/17/1997 | CN1159448A Benzothiophene compounds, intermediates, compositions, and methods |
| 09/17/1997 | CN1159349A Medicine for curing severe bone flourosis and production method thereof |
| 09/16/1997 | US5668138 Affinity for sigma receptors, central nervous system disorders |
| 09/12/1997 | WO1997032865A1 Novel aryl glycinamide derivatives, method of producing said derivatives and pharmaceutical compositions containing these compounds |
| 09/12/1997 | WO1997032846A1 Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
| 09/12/1997 | WO1997032594A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 09/12/1997 | WO1997032591A1 Method of promoting bone growth with hyaluronic acid and growth factors |
| 09/12/1997 | WO1997032583A1 Use of csaidtm compounds as inhibitors of angiogenesis |
| 09/12/1997 | WO1997032575A1 Mercapto derivatives as inhibitors of cyclooxygenases |
| 09/12/1997 | WO1997022698A3 Chemokine receptors 88-2b[ckr-3] and 88c and their antibodies |
| 09/12/1997 | CA2248630A1 Synthetic peptides and pseudopeptides having osteogenic activity and pharmaceutical compositions containing the same |
| 09/12/1997 | CA2199351A1 Benzothiophenes, formulations containing same, and methods |
| 09/11/1997 | DE19608665A1 Neue Arylglycinamidderivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Zusammensetzungen New Arylglycinamidderivate, processes for their preparation containing these compounds and pharmaceutical compositions |
| 09/10/1997 | EP0793649A1 18,19-dinor-vitamin d compounds |
| 09/10/1997 | EP0793648A1 18-nor-vitamin d compounds |
| 09/10/1997 | CN1158850A New thiophene compounds, process for their preparation and pharmaceutical compositions containing them |
| 09/10/1997 | CN1158739A Medicine containing goose egg and its production process |
| 09/09/1997 | US5665777 Biphenyl hydroxamate inhibitors of matrix metalloproteinases |
| 09/09/1997 | CA2136820C Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism |
| 09/04/1997 | WO1997031949A1 Antibodies binding to monocyte chemoattractant protein 1 (mcp-1) receptor (ccr2) |
| 09/04/1997 | WO1997031941A2 Soluble tachykinin antagonists, the preparation and use thereof |
| 09/04/1997 | WO1997031895A2 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/04/1997 | WO1997031640A1 Combination therapy for osteoporosis |
| 09/04/1997 | CA2247802A1 Soluble tachykinin antagonists, the preparation and use thereof |
| 09/04/1997 | CA2247208A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| 09/03/1997 | EP0792878A2 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism |
| 09/03/1997 | EP0792645A1 Combination therapy to treat osteoporosis |
| 09/03/1997 | EP0792639A1 Combination therapy to treat osteoporosis or conditions which present low bone mass |
| 09/03/1997 | EP0792370A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4 |
| 09/03/1997 | EP0792292A2 Orphan receptor |
| 09/03/1997 | CN1158569A Estrogens and prathyroid hormone for treating osteoporosis |
| 09/03/1997 | CN1158257A Universal injury liquid and its prepn. method |
| 09/02/1997 | US5663375 Cell proliferation |
| 09/02/1997 | US5663334 Process for preparing pyrimidyl imidazoles |
| 09/02/1997 | US5663174 Antiinflammatory agents, inhibitor of kinases, antiarthritic agents |
| 09/02/1997 | US5662918 Bone disorders, storage stable |
| 08/28/1997 | WO1997030985A1 Benzothiophenes, and formulations and methods, using same |
| 08/28/1997 | WO1997030709A1 Benzothiophenes, formulations containing same, and methods |
| 08/28/1997 | CA2247130A1 Benzothiophenes, and formulations and methods, using same |
| 08/28/1997 | CA2246721A1 Benzothiophenes, formulations containing same, and methods |
| 08/28/1997 | CA2198534A1 Combination therapy to treat osteoporosis - polyphosphonates or progestins and estrogen agonists |
| 08/27/1997 | EP0791601A2 An agent promoting bone formation and inhibiting bone resorption |
| 08/27/1997 | EP0791591A1 Benzothiophenes, formulations containing same, and methods |
| 08/27/1997 | EP0791590A1 Benzothiophenes, and formulations and methods using same |
| 08/27/1997 | EP0791011A2 Biologically active tgf-beta1 and tgf-beta2 peptides |
| 08/27/1997 | EP0531425A4 Wound healing |
| 08/27/1997 | EP0460116B1 9-substituted-8-unsubstituted-9-deazaguanines |
| 08/27/1997 | CN1157818A 1 alpha, 26-dihydroxy-D-homo-vitamin D3 |
| 08/27/1997 | CN1157719A Percutaneous applied medicine contained gestodene |
| 08/27/1997 | CA2198525A1 Geminal carboxylic acids and esters thereof, pharmaceutical formulations containing them useful in the treatment of bone dysmetabolism |
| 08/26/1997 | US5661174 Guanidinealkyl-1,1-bisphosphonic acid derivatives, process for their preparation and their use |
| 08/26/1997 | US5661140 Treating psoriasis |
| 08/26/1997 | US5661007 Culturing; recovering; purification; administering to induce bone and/or cartilage formation |
| 08/21/1997 | WO1997030056A1 Spiro-ketal derivatives and their use as therapeutic agents |
| 08/21/1997 | WO1997030055A1 Spiro-ketal derivatives and their use as therapeutic agents |
| 08/21/1997 | WO1997023613A3 Cell activation process and reagents therefor |
| 08/21/1997 | WO1997023507A3 New form of amphiregulin, methods for producing and using the same and compositions comprising the same |
| 08/20/1997 | EP0790234A1 Process for the preparation of aromatic nitriles |
| 08/20/1997 | EP0790228A1 Mono- or polyenic carboxylic acid derivative |
| 08/20/1997 | EP0790056A1 Preventive or remedy for diseases caused by abnormalities in cartilage tissues |
| 08/20/1997 | EP0789578A1 Multicatalytic protease inhibitors |
| 08/20/1997 | CN1157617A Heterobicyclic derivatives |
| 08/20/1997 | CN1157568A Hard tissue stimulating agent |
| 08/20/1997 | CN1157566A Phosphonates and parathyroid hormone for osteoporosis |
| 08/20/1997 | CN1157565A Method for treatment of osteoporosis using bone active phosphonates and parathyroid hormone |
| 08/20/1997 | CN1157286A N,N-dimethyl-1-t-butoxycarbonyl-4-phenylpiperidine-4-carboxamide |
| 08/19/1997 | US5658949 Inhibition of tumor necrosis factor by retinoic acid |
| 08/19/1997 | US5658903 Cytokine inhibitors |
| 08/19/1997 | US5658883 Biologically active TGF-β1 peptides |
| 08/19/1997 | US5658882 Methods of inducting formation of tendon and/or ligament tissue comprising administering BMP-12, BMP-13, and/or MP-52 |
| 08/14/1997 | WO1997029131A1 HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a) |
| 08/14/1997 | WO1997029119A1 Fhit proteins and nucleic acids and methods based thereon |
| 08/14/1997 | WO1997029109A1 Pyrazolopyrimidines as crf receptor antagonists |
| 08/14/1997 | CA2539273A1 A fusion protein comprising an interleukin-1 receptor antagonist and uses thereof |
| 08/13/1997 | EP0788514A1 Binding agents for treatment of inflammatory, autoimmune or allergic diseases |
| 08/13/1997 | EP0788513A1 Binding agents to cd23 |
| 08/13/1997 | EP0788362A1 Phosponocarboxylate compounds for treating abnormal calcium and phosphate metabolism |
| 08/13/1997 | EP0788360A1 Boronic ester and acid compounds, synthesis and uses |
| 08/13/1997 | CN1156995A Vitronectin receptor antagonists |
| 08/13/1997 | CN1156609A Prescription for bone setting capsule and process thereof |
| 08/13/1997 | CN1156599A Process for preparing osteoproliferation treating liquid |
| 08/12/1997 | US5656656 Drug for treating osteoporosis bone disorder |
| 08/12/1997 | US5656598 Use of fibroblast growth factors to stimulate bone growth |
| 08/12/1997 | US5656288 Stable pharmaceutical compositions containing tiludronate hydrates and process for producing the pharmaceutical compositions |
| 08/07/1997 | WO1997028280A1 Diagnostic method and apparatus |
| 08/07/1997 | WO1997028161A1 Novel pyrrolo[2,3-d]pyrimidines and their use as tyrosine kinase inhibitors |
| 08/07/1997 | WO1997028155A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | WO1997028148A1 Dihydrobenzofuran compounds useful as anti-inflammatory agents |
| 08/07/1997 | WO1997028147A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | WO1997028145A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | WO1997028144A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | WO1997028143A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | CA2244203A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |
| 08/07/1997 | CA2244199A1 Dihydrobenzofuran and related compounds useful as anti-inflammatory agents |